<?xml version="1.0" encoding="UTF-8"?>
<p>The first exclusive CHIKV seroprevalence study was conducted in 2004 in Kenya, with the re-emergence of the virus causing a large outbreak in 2004 [
 <xref rid="pntd.0006533.ref130" ref-type="bibr">130</xref>]. This study was followed in 2005 by two studies, one in the Grande Comoros Island [
 <xref rid="pntd.0006533.ref131" ref-type="bibr">131</xref>], where an outbreak occurred, and in Mayotte before the 2006 epidemic [
 <xref rid="pntd.0006533.ref132" ref-type="bibr">132</xref>]. In 2006, four studies were conducted on Reunion Island and Mayotte during and after the 2006 epidemic [
 <xref rid="pntd.0006533.ref120" ref-type="bibr">120</xref>,
 <xref rid="pntd.0006533.ref120" ref-type="bibr">120</xref>,
 <xref rid="pntd.0006533.ref132" ref-type="bibr">132</xref>,
 <xref rid="pntd.0006533.ref133" ref-type="bibr">133</xref>] and in Benin, where no cases have been reported [
 <xref rid="pntd.0006533.ref116" ref-type="bibr">116</xref>]. In 2007, three studies were conducted: one in Malaysia [
 <xref rid="pntd.0006533.ref129" ref-type="bibr">129</xref>] (after the 2006 outbreak) when the virus subsequently spread to Asia, one in Gabon before the 2007 outbreak [
 <xref rid="pntd.0006533.ref153" ref-type="bibr">153</xref>] and one in Italy [
 <xref rid="pntd.0006533.ref126" ref-type="bibr">126</xref>] when CHIKV was imported to Europe, causing an outbreak. In 2008, two studies were conducted in India and Malaysia, where two outbreaks occurred [
 <xref rid="pntd.0006533.ref115" ref-type="bibr">115</xref>,
 <xref rid="pntd.0006533.ref125" ref-type="bibr">125</xref>]. In 2009, two studies were conducted in India and Kenya [
 <xref rid="pntd.0006533.ref123" ref-type="bibr">123</xref>,
 <xref rid="pntd.0006533.ref124" ref-type="bibr">124</xref>], and in 2010, a study was conducted in Congo after a 2010 CHIKV outbreak [
 <xref rid="pntd.0006533.ref127" ref-type="bibr">127</xref>]. In 2013, CHIKV emerged in the Americas, and in 2014 and 2015, five studies were conducted in the Caribbean [
 <xref rid="pntd.0006533.ref118" ref-type="bibr">118</xref>,
 <xref rid="pntd.0006533.ref118" ref-type="bibr">118</xref>,
 <xref rid="pntd.0006533.ref119" ref-type="bibr">119</xref>,
 <xref rid="pntd.0006533.ref121" ref-type="bibr">121</xref>] (Saint-Martin, Guadeloupe, Martinique and Puerto Rico) and Central America [
 <xref rid="pntd.0006533.ref122" ref-type="bibr">122</xref>] (Nicaragua) during an outbreak in Saint Martin and post-outbreak in the other locations. One study was conducted in Vietnam in 2015, where little was known about CHIKV transmission and where dengue is endemic [
 <xref rid="pntd.0006533.ref136" ref-type="bibr">136</xref>]. The last study was conducted in 2016 in Brazil in a post-outbreak context [
 <xref rid="pntd.0006533.ref128" ref-type="bibr">128</xref>].
</p>
